Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.00% is 85% below its 5-year average of 6.77%, near the low end of its 5-year range (1.00%–24.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 42.09% below its 12-month average of 1.72%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.00%.
DEBT TO ASSETS RATIO
1.00%
DEBT TO ASSETS RATIO AVG TTM
1.72%
DEBT TO ASSETS RATIO AVG 3Y
1.60%
DEBT TO ASSETS RATIO AVG 5Y
6.77%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.09%
CURRENT VS 3Y AVG
-37.68%
CURRENT VS 5Y AVG
-85.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+895.47%
vs the sector median at left
Equillium, Inc.
Market Cap
$89.78M
Debt to Assets Ratio
1.00%
TTM Avg
1.72%
3Y Avg
1.60%
5Y Avg
6.77%
Market Cap
$88.63M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.10M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.83M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | $89.78M | 1.00% | 1.72% | 1.60% | 6.77% |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 0.27% | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | 0.01% | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $91.96M | 0.56% | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.54M | 0.58% | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $87.50M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $92.18M | 0.02% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $87.10M | 0.02% | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.83M | 0.01% | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $85.52M | 0.09% | N/A | N/A | N/A |
Debt/Assets
1.0%
Debt/Equity
0.01
Current Ratio
23.40
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.00% |
| 2026-03-31 | 1.10% |
| 2025-12-31 | 2.25% |
| 2025-09-30 | 2.16% |
| 2025-06-30 | 2.09% |
| 2025-03-31 | 1.76% |
| 2024-12-31 | 1.50% |
| 2024-09-30 | 1.44% |
| 2024-06-30 | 1.42% |
| 2024-03-31 | 1.65% |
| 2023-12-31 | 1.63% |
| 2023-09-30 | 1.68% |
| 2023-06-30 | 1.74% |
| 2023-03-31 | 12.09% |
| 2022-12-31 | 12.99% |
| 2022-09-30 | 24.88% |
| 2022-06-30 | 19.48% |
| 2022-03-31 | 16.42% |
| 2021-12-31 | 13.80% |
| 2021-09-30 | 10.95% |
| 2021-06-30 | 10.08% |
| 2021-03-31 | 9.37% |
| 2020-12-31 | 11.64% |
| 2020-09-30 | 10.69% |
| 2020-06-30 | 22.16% |
| 2020-03-31 | 19.53% |
| 2019-12-31 | 17.43% |
| 2019-09-30 | 15.26% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.30% |
| 2018-09-30 | 180.59% |
| 2018-06-30 | 0.00% |
